Upcoming Discipline Hearings

Hearing Dates: July 4, 2022, July 5, 2022, July 6, 2022, July 7, 2022, July 8, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amani Awad committed professional misconduct in that she:

• Attempted to bribe, interfere, obstruct, threaten, and/or tamper with one or more witnesses in a hearing before the Discipline Committee of the Ontario College of Pharmacists regarding allegations of professional misconduct against her.

In particular, it is alleged that she:

• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: August 15, 2022, August 16, 2022, August 17, 2022, August 18, 2022, August 19, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amin Dharamsi, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at [the Pharmacy], and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct with respect to the following incidents:

• Between about October 2, 2018 and January 23, 2019, he failed to take appropriate steps to ensure the destruction of narcotics, controlled drugs, and/or targeted substances;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked staff member [Person A] to destroy narcotics, controlled drugs, and/or targeted substances in his absence and/or in a manner contrary to Health Canada’s guidelines for the destruction of narcotics, controlled drugs, and/or targeted substances;
• On one occasion between about October 2, 2018 and January 23, 2019, he removed narcotics, controlled drugs, and/or targeted substances from the Pharmacy’s premises without appropriate documentation and/or justification;
• Between about October 2, 2018 and January 23, 2019, he provided routine pharmaceutical care and/or dispensed prescriptions to himself and to family members;
• On multiple occasions between about October 2, 2018 and January 23, 2019, he attempted to create false and/or misleading pharmacy records by attempting to imitate the signature of another pharmacist on dispensing records, and/or he asked members of the Pharmacy’s staff to assist him in doing so;
• On or about November 1, 2018, he attempted to create false and/or misleading pharmacy records showing the dispensing of medication to patient [Patient 1] at a greater frequency than was actually dispensed, and/or he asked members of the Pharmacy’s staff to assist him in doing so;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to dispense, and/or to assist in the dispensing of, drugs without the markings on the container required by s. 156(3) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
• On at least two occasions between about October 2, 2018 and February 8, 2019, he gave previously-dispensed drugs and/or products to members of the Pharmacy’s staff and asked that they return the drugs and/or products to the Pharmacy’s inventory for resale;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to falsify, and/or to assist him in falsifying, frequency of dispensing forms, and in particular with respect to falsifying the date on which the forms were sent to prescribers;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to falsify, and/or to assist him in falsifying, the Pharmacy’s records relating to documenting the calibration of the Pharmacy’s scale and/or the temperature of the Pharmacy’s refrigerator;
• On multiple occasions between about [specified date A] and [specified date B], he behaved inappropriately toward and/or in the presence of members of the Pharmacy’s staff, including with respect to the following:
  1. he raised his voice, and/or threw objects, and/or shouted, at members of the Pharmacy’s staff;
  2. he hugged and/or kissed staff member [Person B];
  3. he asked staff member [Person B] inappropriately personal questions;
  4. he harassed staff members[ Person B] and [Person A] by persistently contacting them outside of their working hours at their personal contact numbers and/or email addresses;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he practised the profession while his ability to do so was impaired or adversely affected by a substance, condition, dysfunction, disorder or circumstance, including but not limited to Nabilone and/or Suboxone;
• On multiple occasions between about October 2, 2018 and January 23, 2019, including on December 18, 2018, December 20, 2018, and/or January 4, 2019, he referred to himself by the title “Doctor” or an abbreviation thereof, and/or he represented himself as holding the educational degree of Doctor of Pharmacy by using the abbreviation “Pharm. D” after his name, without justification or authority;
• Between about October 2, 2018 and January 23, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) certain identified medication to patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other reasonable basis;
• Between about October 2, 2018 and January 23, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing certain identified medication to patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other basis.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Practised the profession while his ability to do so was impaired or adversely affected by any substance, condition, dysfunction, disorder or circumstance that he knew or ought to have known would impair or adversely affect his ability to practice;
• Inappropriately used a term, title or designation in respect of his practice;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professionals Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular s. 33(1) of the Regulated Health Professions Act, 1991, SO 1991, c 18;
• Contravened a federal, provincial, or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular s. 43 of the Narcotic Control Regulations, CRC, c 1041;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: August 25, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shamez Kassam, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Chapmans Pharmacy in London, Ontario (the “Pharmacy”), committed professional misconduct with respect to the following:

• At various times between about February 2010 and June 12, 2019, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, including:
  1. by instructing staff (or permitting, consenting to or approving, expressly or impliedly, the instruction to staff) to not cancel prescriptions that had been billed but not dispensed to patients, and/or
  2. with respect to certain identified drugs and/or;
• Between about October 1, 2017 and November 30, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions for which the Pharmacy was not entitled to payment, without taking the steps (or ensuring the steps were taken) that were necessary to ensure the reversal of the charges billed by the Pharmacy, with respect to certain identified prescriptions;
• Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program for which he was required to have and maintain records that he did not have and/or maintain;
• Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program and accepted payment for those claims without being entitled to payment;
• At various times between about February 2010 and June 12, 2019, he instructed staff to dispense methadone and/or Suboxone to patients without a pharmacist present to witness the patient’s dose, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• At various times between about February 2010 and June 12, 2019, he instructed staff to dispense prescription medication to patients without ensuring that a pharmacist or registered pharmacy technician had verified the prescription and its preparation, and had signed the prescription hardcopy, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• At various times between about February 2010 and June 12, 2019, he instructed staff to sign prescription hardcopies in a manner intended to or that he ought reasonably to have expected would be confused for a pharmacist’s signature, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• At various times between about May 27, 2014 and June 12, 2019, he failed to ensure appropriate staffing levels in the Pharmacy to enable himself and other staff to maintain the accepted standard of pharmacy practice and to deliver safe and effective patient care;
• Between about December 2016 and February 2017, he instructed staff to dispense reconstituted powdered methadone to patients while billing those patients’ prescriptions as though Methadose had been dispensed, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• Between about January 1, 2016 and December 31, 2018, he failed to report (or ensure the reporting of) a loss or theft of narcotics relating to losses of Hydromorph contin 18mg, 24mg, and/or 30mg, as required by s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
• Between about January 1, 2016 and June 12, 2019, he failed to ensure that inventory reconciliations of narcotics and controlled/targeted substances were performed at least every six months and/or with reasonable/required frequency.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified a record relating to his practice and/or to a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • s. 156(1)(g) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
• Contravened a federal or provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or mixture of drugs or product, and in particular:
  • ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, RSO 1990, c O.10, as amended;
  • s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: October 5, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mourcos Shenouda, as pharmacist and Designated Manager at Upper Ottawa Pharmacy (the Pharmacy), in Hamilton, Ontario, and/or as director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he submitted false or unsubstantiated claims for one or more of certain identified products from on or about January 1, 2018 to on or about August 13, 2020.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, documents that he knew or ought to have known contained false or misleading statements;
• Submitted an account or charge for services and products that he knew was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Angelo Arciero, from in or about January 2012 to in or about December 2018, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Wellcare Heartlake Pharmacy (the “Pharmacy”) in Brampton, Ontario, committed professional misconduct in that he billed, or issued bills, for products that were never dispensed to Patient 1, Patient 2 and/or Patient 3.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Angelo Arciero, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Wellcare Heartlake Pharmacy (the “Pharmacy”) in Brampton, Ontario, committed professional misconduct in that he:

• Failed to keep records as required respecting his patients and/or practice with respect to certain identified drug products;
• Falsified a record relating to his patients and/or his practice with respect to certain identified drug products;
• Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to certain identified drug products;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading with respect to certain identified drug products;
• Billed, or issued bills, for products that were never dispensed for certain identified drug products;
• Prescribed and/or dispensed the drug product Blexten to himself for his own use.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew and/or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Robert Awad, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Aim Drug Mart in London, Ontario, committed professional misconduct in that:

• At various times between about January 1, 2015 and June 10, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, and in particular, with respect to Rebif 132mcg Multi-Dose;
• At various times between about October 20, 2017 to February 11, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, and in particular, with respect to intra-nasal Naloxone Kit (2), DIN 93877256;
• At various times between about January 1, 2015 and December 31, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions that had been billed to the Ontario Drug Benefit program and that required a manual submission to ensure the reversal of the charge, without completing the manual submission, or ensuring that it was done, and therefore without ensuring the reversal of the charge.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice and/or to a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
• Charged a fee that was excessive in relation to the service or product provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mary Azzer, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Family Care Pharmacy in Iroquois Falls, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operates the Pharmacy, committed professional misconduct in that:

• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the Pharmacy operating without a pharmacist being physically present;
• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the sale and/or dispensing of drugs at the Pharmacy while no pharmacist was physically present, with respect to certain identified prescriptions;
• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the dispensing of new prescriptions to patients without the patients being offered counselling by a pharmacist, with respect to certain identified prescriptions;
• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the dispensing of prescriptions to patients without the prescriptions having been checked appropriately by a pharmacist, with respect to certain identified prescriptions;
• On or about June 12, 2019, she signed prescription hardcopies as dispensing pharmacist without having appropriately checked the prescriptions before they were dispensed to patients, with respect to certain identified prescriptions;
• On or about June 12, 2019, she delayed the dispensing of a methadone prescription to a patient experiencing acute opioid withdrawal, rather than directing the person presenting the prescription to a nearby pharmacy that could fill it promptly.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to her practice or a person’s health record;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular s. 146 and s. 149 of the Drug and Pharmacies Regulation Act;
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dumfour David Berko, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at the […] Pharmacy in […], Ontario, in the period from about [Identified Date A] to [Identified Date B], committed professional misconduct in that he:

• Sexually abused a patient, […]
• Failed to maintain appropriate professional boundaries with a patient, […]
• Provided a scheduled drug (Tylenol #3) to a patient, […], without a validly authorized prescription.

In particular, it is alleged that he:

• Sexually abused a patient;
• Failed to maintain a standard of practice of the profession;
• Contravened s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, specifically s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

A motion in this matter was heard on April 27, 2021.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dejan Buric, as a dispensing pharmacist and/or Designated Manager at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor (the Pharmacy), committed professional misconduct with respect to the following:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy from approximately February 1, 2016 to approximately August 22, 2017 for seven identified drugs, or any of them; and/or
• Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy in relation to one or more of certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 5, 15, 17 and/or 23 of the Ontario Drug Benefit Act and/or;
  • sections 18, 25 and 29(1) of Ontario Regulation 201/96, and/or;
  • section 166 of the Drug and Pharmacies Regulation Act;
• Failed to keep records as required respecting his patients;
• Falsified a record relating to his practice;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Augustine Daniar, since May 2019, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at White Cedar Pharmacy in Thunder Bay, Ontario, committed professional misconduct in that he:

• Failed to keep records as required relating to his patients and/or his practice with respect to the drug product Suboxone;
• Falsified a record relating to his patients and/or his practice with respect to the drug product Suboxone;
• Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to the drug product Suboxone;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading with respect to the drug product Suboxone.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Raed Eid, while engaged in the practice of pharmacy as a pharmacist at [Pharmacy A] and/or [Pharmacy B] in [Location], Ontario and after the termination of his employment at the pharmacies, committed professional misconduct in that he:

• attended at [Pharmacy A] on two occasions and yelled at his former employer in public; and/or
• repeatedly called and/or texted his former employer; and/or
• attended at [Pharmacy B] on one or more occasions and video recorded and/or yelled at the owner and staff in the presence of patients; and/or
• sent emails to a number of persons in which he described his former employer and [Related Person] as being, among other things, disgusting and/or disrespectful and/or condescending and/or dishonest and/or racist, and/or incompetent, and/or falsely claimed that his former employer was going to stab him.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Raed Eid, during August 2021, while engaged in the practice of pharmacy as a pharmacist at [Pharmacy Name] in [Location], Ontario, committed professional misconduct in that he:

• Failed to provide a patient known as [Patient 1] with all of the Ramipril she was prescribed and/or verify dose and/or failed to provide [Patient 1] with medication for her daughter and/or was rude to [Patient 1];
• Failed to provide a patient known as [Patient 2] with her medication for depression and/or was rude to [Patient 2];
• Failed to provide a patient known as [Patient 3] with her medication, including but not limited to Elavil;
• Failed to provide patients known as [Patient 4] and [Patient 5] with their medications, including but not limited to [Patient 5]’s insulin;
• Failed to provide a patient known as [Patient 6] with his Keppra and/or provided the patient with the wrong quantity of Kadian;
• Failed to provide a patient known as [Patient 7] with her Cipralex and was rude to [Patient 7]; and/or
• Failed to maintain confidential patient information by questioning [Patient 8]’s mother in public about [Patient 8]’s medical conditions and other personal health information.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shereen El-Azrak committed professional misconduct in that

• On September 25, 2018, in the Superior Court of Justice at Newmarket, she was found guilty of trafficking in fentanyl and possession of fentanyl for the purpose of trafficking, contrary to s. 5 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19.

In particular, it is alleged that she

• Was found guilty of offences that are relevant to her suitability to practice.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Babatunde Fashina, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Thistle Pharmacy in Brampton, Ontario, from about January 1, 2017 to December 31, 2020, committed professional misconduct in that he:

• Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients; and
• Failed to keep records as required with respect to purchase invoices for certain identified drugs.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • ss. 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • ss. 19(k) and 20(1), para. 4 of Ontario Regulation 264/16, made under the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mahwish Fayyaz, while engaged in the practice of pharmacy as dispensing pharmacist at Permanent Drug Mart in Rexdale, Ontario (the “Pharmacy”), committed professional misconduct in that she:

• Provided a controlled drug, as defined in the Food and Drug Regulations, […] without first having been provided a prescription for it;
• Possessed substances included in Schedule I of the Controlled Drugs and Substances Act without being authorized to do so under the Regulations of that Act;
• Provided narcotics […] otherwise than in accordance with the Regulations of the Controlled Drugs and Substances Act;
• Falsified a record relating to her patients and/or her practice with respect to certain identified narcotic drug products;
• Performed an otherwise authorized controlled act for an improper purpose with respect to certain identified narcotic drug products;
• Signed or issued, in her professional capacity, a document she knew and/or ought to have known contained a false and misleading statement with respect to certain identified narcotic drug products;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that she knew and/or ought to have known was false or misleading with respect to certain identified narcotic drug products;
• Engaged in behavior which caused and/or resulted in patients receiving contaminated drug preparations and/or incorrect doses of narcotic drug products and/or pharmacy products that were not purchased or prescribed;

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Performed an otherwise authorized controlled act for an improper purpose;
• Falsified a record relating to her patients and/or her practice;
• Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that she knew and/or ought to have known was false or misleading;
• Contravened, while engaged in the practice of pharmacy at the Pharmacy, a federal, provincial, or territorial law or municipal by-law, including:
  • Section G.03.002 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Section 4 of the Controlled Drugs and Substances Act, S.C. 1996, c.19, as amended;
  • Section 31(1) of the Narcotic Control Regulations under the Controlled Drugs and Substances Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nhu (Vivian) Huynh, while engaged in the practice of pharmacy as a pharmacist at Loblaw Pharmacy located at 875 Highland Road West in Kitchener, Ontario (the “Pharmacy”), committed professional misconduct in that she:

• Removed without authority and/or misappropriated influenza vaccines from the Pharmacy;
• Participated in the unauthorized transport, storage and/or administration of influenza vaccinations;
• Participated in the transport of influenza vaccinations in a manner that had the potential to break the cold chain and/or compromise the safety and/or the efficacy of influenza vaccinations;
• Suggested and/or offered to falsify influenza vaccination records and/or patient records;
• Delayed, limited and/or restricted her patients’ access to influenza vaccinations; and/or
• Acted in a conflict of interest with respect to influenza vaccinations.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Practiced the profession while in a conflict of interest and/or participated in an arrangement that constitutes a conflict;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about August 2014 to February 2018, committed professional misconduct in that he:

• Failed to keep records as required by the College’s Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs;
• Directed non-pharmacist employees to dispense methadone to patients;
• Misappropriated prescription drugs and/or controlled substances from the pharmacy, including:
  • Oxycocet;
  • Tylenol #3 and/or Ratio-Lenoltec #3;
  • Clonazepam; and/or
  • Tramadol.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required;
• Contravened s. 149(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically
  • s. 4 of the Controlled Drugs and Substances Act;
  • s. 51(1) of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217;
  • s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about December 2015 to April 2019, committed professional misconduct in that he:

• Failed to report to the Registrar that he had been charged criminally with offences under the Controlled Drugs and Substances Act on or about December 24, 2015;
• Unlawfully possessed the following controlled substances without a prescription when stopped by police in King Township, Ontario on December 24, 2015:
  • Oxycontin;
  • Oxycocet;
  • Oxycodone; and/or
  • Morphine.

In particular, it is alleged that he:

• Contravened a term, condition or limitation imposed on his certificate of registration;
• Failed to maintain a standard of practice of the profession;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically:
  • s. 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Babak Khazra, while engaged in the practice of pharmacy as a dispensing pharmacist at Blair Court Pharmacy (Accreditation Number 303254) in Toronto, Ontario (the “Pharmacy”), and/or as a director and shareholder of the corporation that owned and operated the Pharmacy, in or about March and April 2020, committed professional misconduct in that he:

• Submitted accounts or charges for services that he knew or reasonably ought to have known were false or misleading to the Ontario Drug Benefit program for some or all of 78 MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or
• Falsified pharmacy records in relation to claims made to the Ontario Drug Benefit Program for some or all of 78 MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or
• Failed to document and/or retain records for some or all of 78 MedsCheck services as required by the MedsCheck program and pharmacy regulations; and/or
• Failed to ensure the confidentiality of patient records.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • Section 15(1) of the Ontario Drug Benefit Act;
  • Sections 27 and/or 29 of O. Reg. 201/96, made under the Ontario Drug Benefit Act;
  • Sections 20 and/or 21 of O. Reg. 264/16, made under the Drug and Pharmacies Regulation Act; and/or
  • Section 12 of the Personal Health Information Protection Act, 2004;
• Failed to keep records as required respecting his patients or practice;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Hany Komy, while engaged in the practice of pharmacy as […] at [the Pharmacy] in […], Ontario, committed professional misconduct in that he:

• Failed to maintain a professional boundary in respect of patient [Name], in the period from about [Specified Date 1] to [Specified date 2];
• Dispensed controlled-release oxycodone to patient [Name] on or about [Date A], [Date B], [Date C], and/or [Date D], instead of the short-acting oxycodone that had been prescribed.

In particular, it is alleged that he:

• Sexually abused a patient, [Name];
• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Hany Komy, while engaged in the practice of pharmacy as […] at the […] Pharmacy in […], Ontario, from about [Specified Date A] to [Specified Date B], committed professional misconduct in that he inappropriately touched a pharmacy employee, [Name].

In particular, it is alleged that he engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jaak Kubar, as dispensing pharmacist and/or Designated Manager of Burlington Drug Mart at 701 Guelph Line in Burlington, Ontario (the Pharmacy), and/or as a shareholder of the corporation that owned the Pharmacy, committed professional misconduct between approximately January 31, 2018 and July 31, 2020, in that he:

• Dispensed narcotic prescriptions to a single patient from two or more different prescribers without exercising appropriate professional diligence, communicating pertinent information to prescribers, and/or making adequate inquiries with the prescribers for one or more of certain identified drugs;
• Dispensed a monitored drug to one or more patient(s) without submitting the required information to the Narcotics Monitoring System as required by s. 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22 and the Notice issued thereunder for one or more of certain identified transactions;
• Failed to adequately document the actions, if any, taken in response to, and/or the reasons for not taking any action in response to, one or more of certain identified Narcotics Monitoring System alerts; and/or
• Permitted and/or assisted a patient to conceal authorizations for Schedule I controlled substances from another prescriber, contrary to s. 4(2) of the Controlled Drugs and Substances Act.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required with respect to his patients or practice;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular: s. 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22;
• Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Accreditation Committee, it is alleged that Paul Lee, as Designated Manager of Specialty Rx (the “Pharmacy”), and as director Ottawa Pharmacy Group Inc. 4008255, c.o.b. as Specialty Rx and to whom the certificate of accreditation for the Pharmacy was issued, committed proprietary misconduct in that he:

• Failed to keep documents as required respecting patients, the operation of the Pharmacy and/or the practice of members practising in the Pharmacy;
• Returned to stock, resold, or re-dispensed a drug that was previously sold or dispensed; and/or
• Dispensed, sold or compounded a drug, or administered a substance, that was not of good quality and/or did not meet the standards required by law.

In particular, it is alleged that Paul Lee and Ottawa Pharmacy Group Inc. 4008255, as holder of the certificate of accreditation for Specialty Rx:

• Failed to maintain a standard of accreditation;
• Failed to keep documents as required respecting patients, the operation of the Pharmacy and/or the practice of members practising in the Pharmacy;
• Returned to stock, resold or re-dispensed a drug that was previously sold or dispensed;
• Dispensed, sold or compounded a drug, or administered a substance, that was not of good quality and/or did not meet the standards required by law;
• Engaged in conduct or performing an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Yong Lin, while practicing pharmacy as the Designated Manager and/or dispensing pharmacist at the Life Compounding Pharmacy in Richmond Hill, Ontario, in the period from about August 10, 2019, to November 22, 2020, committed professional misconduct in that he:

• Failed to recognize the limits of his competence with respect to the dispensing of drugs prescribed by veterinarians and taking insufficient steps to acquire such competence; and
• Failed to exercise reasonable diligence in scrutinizing the prescriptions purportedly issued by Dr. [Name A] and Dr. [Name B].

In particular, it is alleged that he:

• Failed to maintain a standard or standards of practice;
• Performed a professional service without the requisite knowledge or skill;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Accreditation Committee, it is alleged that Michael Marini, the Designated Manager of Dover Apothecary in Port Dover, Ontario (the “Pharmacy”), and the Director of 740894 Ontario Inc., c.o.b. as Dover Apothecary and to which Certificate of Accreditation #30204 for the Pharmacy was issued, committed proprietary misconduct in that they:

• Failed to have available the references and resources for compounding that are required by members practising in the pharmacy to meet the standards of practice of the profession and to support the pharmacy services the members provide; and/or
• Failed to have the necessary systems to allow members of practicing in the Pharmacy to meet the standards of practice of the profession with respect to compounding;
• Failed to respond to the College’s request for an action plan in relation the Level III Assessment between on or about May 14, 2019 to on or about June 8, 2019; Level IV Assessment between on or about November 12, 2019 to on or about December 20, 2019; and/or Level V Assessment between on or about January 28, 2022 to on or about February 4, 2022; and/or
• Failed to respond to the College’s request for narcotic reconciliation records for the period of on or about February 24, 2021 to October 2021; and/or
• Failed to take all reasonable steps to correct some or all of the deficiencies identified in the Assessment Reports of June 20, 2018; October 23, 2018; May 6, 2019, and/or October 30, 2019 with respect to narcotics, controlled drugs and targeted substances reconciliation practices; compounding; and/or the patient consultation area, as identified; and/or
• Failed to conduct monthly narcotic reconciliations and/or submit them to the College’s Manager of Conduct Operations; and/or
• Failed to take steps to ensure that patient personal information is protected; and/or
• Failed to implement and follow policies and procedures to ensure all refrigerators that store medication are maintained at a temperature between 2 and 8 degrees Celsius.

In particular, it is alleged that Michael Marini, the Designated Manager of Dover Apothecary in Port Dover, Ontario (the “Pharmacy”), and the Director of 740894 Ontario Inc., c.o.b. as Dover Apothecary and to which Certificate of Accreditation #30204 for the Pharmacy was issued:

• Failed to maintain a standard of accreditation;
• Failed to reply within a reasonable time to a written or electronic inquiry or request from the College;
• Failed to carry out or abide by an undertaking given by the pharmacy to the College;
• Engaged in conduct or performing an act relevant to the operation of a pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Bichoy Maurice, as a shareholder and/or director at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor, Ontario (the Pharmacy), committed professional misconduct with respect to the following:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $720,053.73 between August 22, 2015 and August 22, 2017 for seven identified drugs, or any of them; and/or
• Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy totaling approximately $23,894.70 in relation to one or more of certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 5, 15, 17, 18 and/or 23 of the Ontario Drug Benefit Act; and/or
  • sections 18, 25 and/or 29(1) of Ontario Regulation 201/96; and/or
  • section 166 of the Drug and Pharmacies Regulation Act;
• Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

A motion in this matter was heard on January 28, 2022.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mina Michael, as a shareholder and/or director at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor, Ontario (the Pharmacy), committed professional misconduct with respect to the following:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $720,053.73 between August 22, 2015 and August 22, 2017 for seven identified drugs, or any of them; and/or
• Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy totaling approximately $23,894.70 in relation to one or more of certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 5, 15, 17, 18 and/or 23 of the Ontario Drug Benefit Act; and/or
  • sections 18, 25 and/or 29(1) of Ontario Regulation 201/96; and/or
  • section 166 of the Drug and Pharmacies Regulation Act;
• Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

A motion in this matter was heard on January 28, 2022.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and/or Designated Manager at Pars Medical Pharmacy in Richmond Hill, committed professional misconduct in that he

• Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Obtained new prescriptions and/or prescription refills for himself for certain identified prescriptions;
• Dispensed prescription medications to himself in relation to certain identified prescriptions; and/or
• Submitted claims to [Insurer] for 200 diabetic test strips for himself on or about October 27, 2014, as though the prescription had been authorized by him in accordance with the regulations under the Pharmacy Act, 1991 which was not accurate, and/or then falsified a record retroactively to indicate that the claim had been authorized by a physician before being submitted.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Practised the profession while he was in a conflict of interest
• Failed to keep records as required respecting his patients
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and Designated Manager at Pars Medical Pharmacy in Richmond Hill, Ontario, and as shareholder of Ultra Care Pharmacy Inc., the owner and operator of the Pharmacy, committed professional misconduct in that he

• Submitted false or unsubstantiated claims to the Ontario Drug Benefit Program totalling approximately $80,000.00 in relation to nine identified drug and/or other health products in or about January 2013-March 2015; and/or
• Created false records of billing and/or dispensing transactions in relation to the false or unsubstantiated claims submitted to the Ontario Drug Benefit Program in relation to nine identified drug and/or other health products in or about January 2013-March 2015

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Ontario Drug Benefit Act, R.S.O. 1990 c.O. 10, sections 5, 6 and/or 15, as amended, and/or Ontario Regulation 201/96, section 27
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Abdullah Musa, from in or about May 2016 to August 2019, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Morrish Pharmacy in Scarborough, Ontario, committed professional misconduct in that he:

• Failed to keep records as required respecting his patients and/his practice with respect to one or more of certain identified drugs and/or products;
• Falsified a record relating to his patients and/or his practice with respect to one or more of certain identified drugs and/or products;
• Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to one or more of certain identified drugs and/or products;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products; and/or
• Charged, or issued charges, for products that were never dispensed to patients with respect to one or more of certain identified drugs and/or products.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jason Newman, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Delaware Pharmacy in Delaware, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operates the Pharmacy, committed professional misconduct in that, between May 25, 2017 and May 25, 2019, he submitted false and/or unsubstantiated claims for one or more of certain identified drugs or products.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Vu Nguyen, while engaged in the practice of pharmacy as Designated Manager, Director, owner and/or shareholder of Deer Ridge Pharmacy located at B-4281 King St. East in Kitchener, Ontario (the “Pharmacy”), committed professional misconduct in that he:

• Participated in the diversion and/or misappropriation of influenza vaccines to the Pharmacy;
• Administered influenza vaccinations for which there was a potential break in the cold chain and/or which may have been compromised;
• Stored and/or administered influenza vaccinations in an unsafe location or manner;
• Suggested and/or offered to falsify influenza vaccination records and/or patient records; and/or
• Practiced the profession while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Practiced the profession while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Diep Nguyen, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at Brighton Global Health in Brighton, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct with respect to the following incidents:

1. on or about November 25, 2020, and in the period following that date, he closed the Pharmacy without complying with the requirements for closing a Pharmacy, and in particular:
   1. he failed to remove and dispose of all drugs according to law, contrary to s. 141 of the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
   2. he failed to submit to the Registrar a Pharmacy Closing Statement, contrary to s. 141 of the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
2. on or about November 25, 2020 to February 5, 2021 he failed to adequately reply within a reasonable time to requests from the College relating to the closure of the Pharmacy.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular: s. 141 of the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amro Noureldin, while engaged in the practice of pharmacy as a relief pharmacist and/or dispensing pharmacist at Shoppers Drug Mart Pharmacy […] in Kenora, Ontario (the “Pharmacy”), committed professional misconduct in that he stole, misappropriated, and/or took without authorization drugs from the Pharmacy, including but not limited to controlled drugs and substances.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened a federal law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, whose purpose is to protect or promote public health, and/or that is otherwise relevant to his suitability to practise, and in particular theft under $5,000, contrary to section 334(b) of the Criminal Code, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming of a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Samuel Osaseri, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist, committed professional misconduct in that he:

• Sexually abused a patient, [Person A];
• Sexually harassed one or more of the following pharmacy employees: [Person B], [Person C], [Person A], [Person D], [Person E]; and/or sexually abused patient/employee [Person A].

In particular, it is alleged that he:

• Sexually abused a patient;
• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Manish Patel, in his role as pharmacist, director and/or shareholder at Superseven Pharmacy, committed professional misconduct with respect to the making of, labelling of, sale or dispensing of and/or recordkeeping for the Energy Booster secretagogue.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, in particular but not limited to the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and Ontario Regulation 264/16 under that Act;
• Contravened any federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, in particular but not limited to the Natural Health Products Regulations, SOR/2003-196;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dhaval Kiranbhai Patel, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Shoppers Drug Mart Pharmacy in Windsor, committed professional misconduct in that he:

• Directed (or permitted, consented to, or approved, expressly or by implication) a pharmacy technician to perform controlled acts limited to pharmacists and/or perform acts outside her scope of practice, including but not limited to, performing the clinical verification/therapeutic check of dispensed prescriptions;
• Failed to clinically verify or perform a therapeutic check on dispensed prescriptions;
• Falsified (or directed, permitted, consented to, or approved, expressly or by implication, the falsification of) records indicating that he had performed the clinical verification/therapeutic check of dispensed prescriptions; and/or
• Failed to take reasonable steps to protect narcotics and/or controlled substances at the Pharmacy from loss or theft, including but not limited to, failing to conduct, and/or maintain a record of, adequate reconciliations for narcotics and/or controlled substances and/or failing to report losses to Health Canada as required.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to provide an appropriate level of supervision to a person he was professionally obligated to supervise;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Contravened a federal law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, whose purpose is to protect or promote public health, and/or that is otherwise relevant to his suitability to practise, and in particular
  • Sections 42 and 43 of the Narcotic Control Regulations, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Leon Rawa, while being a pharmacist and/or Designated Manager at Dufferin Central Pharmacy located at 1649 Dufferin St., in Toronto (the “Pharmacy”) and/or while being a director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he submitted false or unsubstantiated claims for one or more of certain identified products from on or about January 1, 2018 to on or about December 31, 2018.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, documents that he knew or ought to have known contained false or misleading statements;
• Submitted an account or charge for services or products that he knew or ought to have known were false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Leon Rawa, while being a pharmacist and/or Designated Manager at Dufferin Central Pharmacy located at 1649 Dufferin St., in Toronto (the “Pharmacy”) and/or while being a director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he submitted false or unsubstantiated claims for one or more of certain identified products from on or about August 1, 2018 to on or about July 31, 2020.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, documents that he knew or ought to have known contained false or misleading statements;
• Submitted an account or charge for services or products that he knew or ought to have known were false or misleading;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, contrary to paragraph 23 of subsection 2(1) of Ontario Regulation 130/17, and in particular he contravened section 15(1)(b) of the Ontario Drug Benefit Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Bishoy Salama, while engaged in the practice of pharmacy as owner, director, shareholder, Designated Manager, and/or dispensing pharmacist at Green Pharmacy in Toronto, Ontario, Fort Frances Clinic Dispensary in Fort Frances, Ontario, and/or Pharmasave Fort Frances in Fort Frances, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims for MedsChecks that were not conducted, where the required documentation was not completed, and/or were otherwise non-compliant with the requirements set forth by the Ministry of Health and Long-Term Care between in or about August 2018 and in or about October 2020;
• Provided pharmaceutical care to himself and/or signed prescription hardcopies for his own medications between in or about January 2020 and in or about December 2020; and/or
• Failed to sign prescription hardcopies for medications he dispensed, signed prescription hardcopies that he did not dispense, and/or permitted staff to dispense medications without signing prescription hardcopies between in or about August 2019 and in or about January 2021.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement;
• Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Saleh committed professional misconduct in that

• On or about September 14, 2017, he committed Sexual Assault, contrary to section 271 of the Criminal Code of Canada, for which he was found criminally guilty on March 6, 2019.

In particular, it is alleged that he

• Has been found guilty of an offence that is relevant to his suitability to practice;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sina Salehi, committed professional misconduct with respect to the following incidents:

• While engaged in the practice of pharmacy as Designated Manager at Doctors Pharmacy in Scarborough, Ontario (“Doctors Scarborough”), and/or as a shareholder and/or director of the corporation that operated the pharmacy,

1. 1. between about January 1, 2019, and January 15, 2021, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) prescription drugs to unauthorized recipients and/or sources, with respect to certain identified prescription drugs;
   2. between about January 1, 2019, and January 15, 2021, he submitted (or permitted, consented to, or approved, expressly or impliedly, the submission of) false or unsubstantiated claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
   3. between about January 1, 2019, and January 15, 2021, he dispensed (or permitted, consented to, or approved, expressly or impliedly, the dispensing of) prescription drugs without valid authorization, with respect to certain identified prescriptions;
   4. between about January 1, 2019, and January 15, 2021, he failed to ensure that inventory reconciliations of narcotics and controlled substances were performed at least once every six months, and/or he failed to ensure that records of such reconciliations were retained as required;
   5. between about January 1, 2019, and January 15, 2021, he failed to report the loss or theft of narcotics as required by s. 42 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, and/or he failed to take all reasonable steps necessary to protect narcotics on his premises or under his control against loss or theft as required by s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;

• While engaged in the practice of pharmacy as Designated Manager at Doctors Pharmacy in Thornhill, Ontario (“Doctors Thornhill”), and/or as a shareholder and/or director of the corporation that operated the pharmacy,

1. 1. between about April 1, 2019, and January 15, 2021, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) prescription drugs to unauthorized recipients and/or sources, with respect to certain identified prescription drugs;
   2. between about April 1, 2019, and January 15, 2021, he submitted (or permitted, consented to, or approved, expressly or impliedly, the submission of) false or unsubstantiated claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
   3. between about April 1, 2019, and January 15, 2021, he dispensed (or permitted, consented to, or approved, expressly or impliedly, the dispensing of) prescription drugs without valid authorization, with respect to certain identified prescriptions;
   4. between about April 1, 2019, and January 15, 2021, he failed to ensure that inventory reconciliations of narcotics and controlled substances were performed at least once every six months, and/or he failed to ensure that records of such reconciliations were retained as required;
   5. between about April 1, 2019, and January 15, 2021, he failed to report the loss or theft of narcotics as required by s. 42 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, and/or he failed to take all reasonable steps necessary to protect narcotics on his premises or under his control against loss or theft as required by s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;

• While engaged in the practice of pharmacy at Neighbour’s Drug Mart in Thornhill, Ontario (“Neighbour’s Drug Mart”), and/or as a shareholder and/or director of the corporation that operated the pharmacy,

1. 1. between about August 4, 2020, and January 15, 2021, he diverted (or permitted, consented to, or approved, expressly or impliedly, the diversion of) prescription drugs to unauthorized recipients and/or sources, with respect to certain identified prescription drugs;
   2. between about August 4, 2020, and January 15, 2021, he submitted (or permitted, consented to, or approved, expressly or impliedly, the submission of) false or unsubstantiated claims for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
   3. between about August 4, 2020, and January 15, 2021, he failed to report the loss or theft of narcotics as required by s. 42 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, and/or he failed to take all reasonable steps necessary to protect narcotics on his premises or under his control against loss or theft as required by s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act;

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified a record relating to his practice or a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts:
  • s. 155 of the Drug and Pharmacies Regulation Act
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis:
  • s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act
  • s. 42 and/or s. 43 of the Narcotic Control Regulations made under the Controlled Drugs and Substances Act
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist in Ottawa, Ontario, committed professional misconduct in that he

• Engaged in the trafficking of controlled substance with respect to certain identified items
• Dispensed drugs and/or products for which prescriptions are legislatively required without an authorized prescriber’s authorization as set out for certain identified items
• In or about the period from January 2013 to March 2015, he failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs
• Submitted accounts or charges for services that he knew were false or misleading to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
• Falsified pharmacy records relating to his practice in relation to claims made to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
• From approximately January 2013 to March 2015, he used his position as pharmacist to traffic in narcotics, in particular fentanyl patches
• Procured an individual to carry out a simulated robbery of the IDA Rideau Pharmacy on October 26, 2014
• Made a report to the […] Police in respect of a robbery allegedly committed on October 26, 2014, knowing that the report was false

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting his patients
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement with respect to the certain identified forged prescriptions
• Submitted accounts or charges for services that he knew to be false or misleading
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts with respect to the following incidents:
  • Dispensing drugs and/or products in the absence of a prescription authorized by a prescriber in contravention of s. 40 of Ontario Regulation 58/11 under the Drug and Pharmacies Regulation Act and ss. 155 and 156
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, and in particular, with respect to the following incidents:
  • Trafficking controlled substances in contravention of s. 5 of the Controlled Drugs and Substances Act
  • Dispensing drugs in the absence of a prescription authorized by a prescriber in contravention of s. 31 of the Narcotic Control Regulation
  • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of C.01.041 of the Food and Drug Regulations
  • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of G.03.002 of the Food and Drug Regulations
• Knowingly permitted the premises in which the pharmacy was located to be used for unlawful purposes
• Permitted, consented to or approved, either expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen committed professional misconduct in that he

• Failed to comply with the decision of the Inquiries, Complaints and Reports Committee dated May 10, 2016, in that he failed to successfully complete the Professional Problem-Based Ethics workshop offered by the Center for Personalized Education for Physicians, at his own expense, within 12 months of the date of that decision, and provide proof thereof to the College.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, namely: he contravened s. 26(3) of the Health Professions Procedural Code
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at IDA Rideau Medical Pharmacy in Ottawa, Ontario, between May 2, 2011 and June 17, 2015, committed professional misconduct in that he

• Falsified pharmacy records relating to his practice in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
• Submitted an account or charge for services that he knew was false or misleading in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified pharmacy records relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Shehata, from in or about July 2018 to in or about September 2020, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at True Vine Pharmacy in Hamilton, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) an account or charge for services or products that he knew and/or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products;
• Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) a record regarding his patients and/or his practice with respect to one or more of certain identified drugs and/or products;
• Signed or issued, in his professional capacity, (or permitted, consented to, or approved, expressly or by implication, the signing or issuance of) a document he knew and/or ought to have known contained a false and/or misleading statement with respect to one or more of certain identified drugs and/or products; and/or
• Failed to keep records as required regarding his patients and/or his practice with respect to one or more of certain identified drugs and/or products.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) an account or charge for services or products that he knew and/or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michelle Shim, since in or around June 2017, while acting as Designated Manager, dispensing pharmacist and/or in any other capacity at Innomar Specialty Pharmacy in Barrie, Ontario, APlusPharma Ltd., Innomar Strategies Inc. and/or any other corporate entity affiliated with APlusPharma and/or Innomar Strategies, committed professional misconduct in that she:

• Practised the profession while in a conflict of interest as defined in Part II of Ontario Regulation 130/17 in relation to the drug product XYREM;
• Participated in an arrangement that constitutes a conflict of interest as defined in Part II of Ontario Regulation 130/17 with respect to the drug product XYREM;
• Entered into an agreement, in relation to the drug product XYREM, that restricted a person’s choice of a pharmacist without the consent of the person;
• Solicited and/or permitted the solicitation of patients to the Pharmacy in relation to the drug product XYREM; and/or,
• Participated in the transition to dispensing XYREM to the Pharmacy exclusively through the Pharmacy in a manner that contravened the principles of Beneficence, Respect for Persons/Justice and Accountability (Fidelity) in the Ontario College of Pharmacists Code of Ethics.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Practised the profession of pharmacy while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest;
• Entered into an agreement that restricted one or more persons choice of a pharmacist without the consent of those person(s);
• Solicited and/or permitted the solicitation of one or more patients to the Pharmacy;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Soha Shoala, while being a pharmacist and/or Designated Manager at All Care Pharmacy located in Mississauga (the “Pharmacy”) and/or while being a director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that she:

• Failed to keep records as required respecting her practice with respect to one or more of certain identified products from on or about January 1, 2017 to on or about December 31, 2017; and/or
• Failed to have systems in place to maintain an audit trail of the acquisition and movement of products from on or about January 1, 2017 to on or about December 31, 2017;
• Submitted false or unsubstantiated claims for one or more of certain identified products from on or about January 1, 2017 to on or about December 31, 2017.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting her practice;
• Falsified records relating to her practice;
• Signed or issued, in her professional capacity, documents that she knew contained false or misleading statements;
• Submitted an account or charge for services and products that she knew were false or misleading;
• Contravened a regulation under the Drug and Pharmacies Regulation Act, and in particular sections 19 and 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Luke Skywalker, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Blossom Park Pharmacy located at 2928 Bank Street in Ottawa, Ontario (the “Pharmacy”), committed professional misconduct in that he:

• Submitted (or permitted, consented to or approved, expressly or by implication, the submission of) false, misleading, inaccurate, and/or unsubstantiated claims to the Ontario Drug Benefit Program (“ODBP”) for one or more of certain identified drugs and/or products listed and/or one or more of certain identified claims; and/or
• Failed to keep records as required with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims submitted to the Ontario Drug Benefit Program and/or one or more of certain other identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Submitted an account(s) or charge(s) for services that he knew and/or ought to have known was false or misleading;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs and in particular:
  • section 15 of the Ontario Drug Benefit Act, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about September 13, 2017 to May 23, 2019, committed professional misconduct in that he submitted false claims for one or more of certain identified drugs and other products when a different product was actually dispensed to patients.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about January 1, 2016 to May 23, 2019, committed professional misconduct in that he submitted false claims for one or more of certain identified drugs and other products when a different product was actually dispensed to patients.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about June 15, 2017 to August 29, 2019, committed professional misconduct in that he:

• Submitted false claims for one or more of certain identified drugs and other products when a different product was actually dispensed to patients;
• Dispensed free samples of prescription medication, namely compounded pain cream, without valid authorization.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about January 1, 2016 to May 23, 2019, committed professional misconduct in that he submitted claims to [Claims Adjudicator] that included markups on drug products that were excessive and unreasonable.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Charged a fee that was excessive in relation to the service provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about January 9, 2018 to May 29, 2019, committed professional misconduct in that he dispensed and/or billed for certain identified prescription products in absence of a valid prescription.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about December 11, 2019 to about May 5, 2020, committed professional misconduct in that he caused prescriptions to be processed and billed through Main Drug Mart in Thornhill under the auspices of a central fill agreement.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Renee St. Jean, since in or around March 2019, while acting as director, shareholder, owner, Designated Manager, dispensing pharmacist and/or in any other capacity at APlusPharma Ltd., Innomar Strategies Inc. and/or any other corporate entity affiliated with APlusPharma, Innomar Strategies, and/or Innomar Specialty Pharmacy in Barrie, Ontario, committed professional misconduct in that she:

• Practised the profession while in a conflict of interest as defined in Part II of Ontario Regulation 130/17 in relation to the drug product XYREM;
• Participated in an arrangement that constitutes a conflict of interest as defined in Part II of Ontario Regulation 130/17 with respect to the drug product XYREM;
• Entered into an agreement, in relation to the drug product XYREM, that restricted a person’s choice of a pharmacist without the consent of the person;
• Solicited and/or permitted the solicitation of patients to the Pharmacy in relation to the drug product XYREM; and/or,
• Participated in the transition to dispensing XYREM to the Pharmacy exclusively through the Pharmacy in a manner that contravened the principles of Beneficence, Respect for Persons/Justice and Accountability (Fidelity) in the Ontario College of Pharmacists Code of Ethics (the “Code of Ethics”).

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Practised the profession of pharmacy while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest;
• Entered into an agreement that restricted one or more persons choice of a pharmacist without the consent of those person(s);
• Solicited and/or permitted the solicitation of one or more patients to the Pharmacy;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mehari Tekeste, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Ossington Medical Pharmacy in Toronto, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operates the Pharmacy, committed professional misconduct with respect to the following incidents:

• Between about January 1, 2019 and August 26, 2020, he dispensed and/or sold (or permitted, consented to or approved, expressly or impliedly, the dispensing and/or selling of) certain identified prescription drugs without a prescription;
• Between about January and April 2020, he permitted, consented to or approved, expressly or impliedly, a staff member who was not a member of the College dispensing and/or selling a drug and/or supervising the part of the Pharmacy where drugs are kept, when no pharmacist was physically present in the Pharmacy;
• Between about January 1, 2019 and August 26, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified drugs and/or products that were not dispensed;
• Between about January 1, 2019 and August 26, 2020, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of certain identified drugs and/or products that were not dispensed;
• He misappropriated certain identified sample medication from the physician’s office adjacent to the Pharmacy;
• Between about January 1, 2019 and August 26, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for sample medication that the Pharmacy was not charged for, and in particular, with respect to charges for Synjardy, Xarelto and Invokana;
• He permitted, consented to or approved, expressly or impliedly, a staff member documenting that he had performed clinical verification of certain identified prescriptions, when he had not.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice or a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • s. 155 of the Drug and Pharmacies Regulation Act;
  • s. 149 of the Drug and Pharmacies Regulation Act and s. 27 of the Regulated Health Professions Act, 1991;
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular:
  • s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Anhal Yacob, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at College Centre Pharmacy located at 528 College Street in Toronto, Ontario (the Pharmacy), committed professional misconduct in that he:

1. Submitted false or unsubstantiated claims to [Insurance Provider]:
   1. between approximately December 1, 2017 and January 31, 2019 for one or more of certain identified products; and/or
   2. for one or more of certain identified prescriptions that were not actually dispensed to patients;
2. Falsified records between approximately December 1, 2017 and January 31, 2019 in respect of one of more of certain identified products and/or in respect of one or more of certain identified prescriptions.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Submitted an account(s) or charge(s) for services that he knew and/or ought to have known were false or misleading;
• Failed to keep records as required respecting his patients or practice;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act; and/or
  • sections 18, 19, and 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Medhat Zekry, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at The Hamilton Clinic pharmacy in Hamilton, Ontario (the “Pharmacy”), committed professional misconduct with respect to the following incidents:

• Between about July 18, 2016 and October 26, 2016, he failed to ensure that appropriate policies were in place and/or that Pharmacy staff followed appropriate policies relating to the destruction of drugs and/or the personal health information of patients of the Pharmacy;
• Between about July 18, 2016 and October 26, 2016, he failed to ensure that appropriate policies were in place and/or that Pharmacy staff followed appropriate policies relating to the transfer of custody of narcotic medication for methadone maintenance treatment programs;
• Between about July 18, 2016 and December 2018, he failed to ensure the security and/or destruction of drugs and/or the personal health information of patients of the Pharmacy, with respect to items recovered from [Storage Facility] in [Place], Ontario.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.